Toggle navigation
About Us
Business Areas
R & D
Manufacturing
Beyond Business
Investors
Careers
Contact Us
Investors
Investors > FY 2015-16
Overview
Chairman's Statement
Shareholder Information
Policies or Statutory Documents
IEPF
Debentures
Amalgamation
MOA/AOA
Procedure for Dematerialisation of Shares
Archives
Credit Ratings
CSR
AGM Transcript
Annual Return
Disclosures under Regulation 46 and 62 of SEBI LODR
Financial
2023-24
2022-23
2021-22
2020-21
2019-20
2018-19
2017-18
2016-17
2015-16
2014-15
2013-14
2012-13
2011-12
Investors > FY 2015-16
1. Annual Report
Zyg Pharma Pvt Ltd
Zao Torrent Pharma
Torrent Pharma S.R.L
Torrent Pharma Philippines Inc
Torrent Pharma Inc
Torrent Pharma GmbH
Torrent Pharma France S.A.S.
Torrent Pharma Canada Inc
Torrent Pharma (UK) Ltd
Torrent Pharma (Thailand) Co., Limited
Torrent Do Brasil Ltda
Torrent Australasia Pty Ltd
Norispharm GmbH
Laboratorios Torrent, S.A. de C.V
Laboratorios Torrent (Malaysia) SDN.BHD
Heunet Pharma GmbH
Heumann Pharma GmbH & Co. Generica KG
Aptil Pharma Limited
Annual Report
2. Intimation to Stock Exchange
Torrent to acquire 100% stake in Zyg Pharma
Torrent Pharma’s new Plant at Dahej Commences operations
Torrent Pharma forays into super specialty segment and launches Adfrar – biosimilar Adalimumab
Torrent Pharma’s Dahej Plant receives EIR from US FDA
Torrent Pharma seeks Shareholder Approval for Equity Raise and Borrowing Plans
Shareholding Pattern Q4
Shareholding Pattern Q3
Shareholding Pattern Q1
Intimation of Press Release Acquiring Glochem Industires
Newspaper Notice of 43rd AGM and E-voting procedure
43rd AGM Chairman Result and Scrutinizer Report
Intimation of Proceedings of 43rd AGM
43rd AGM Notice
Payment of interest on secured redeemable Non-Convertible Debenture(NCDs)
Notice of Record date for debenture interest payment 21st June 2016
Intimation for Results 23rd May, 2016
Newspaper Advertisement Board Meeting 23rd May. 2016
Intimation for Concall with Investors / Analysts- Q4 2015-16
Intimation of Board Meeting 23rd May 2016
Intimation for Issuance of Debentures and Bonds 23rd March 2016
Intimation of Board Meeting 23rd March 2016
Intimation of Dividend 9th March 2016
Intimation of the date of Board Meeting and record date 9th March 2016
Newspaper advertisement of Financial results
Newspaper Advertisement Board Meeting 4th Feb. 2016
Intimation of the Results and Dividend 4th Feb 2016
Intimation of the date of Board Meeting dated 4th Feb 2016
3. Quarterly Results
Q1 15-16
Q2 15-16
Q3 15-16
Q4 15-16
Press Release on Q1 Results
Q1 Segmentwise Investor Update
Investors Update Q1
Investors Presentation
Q1, FY 2016 Con call Transcript
Q1, FY 2016 Con call Transcript
Stand Alone Results
Consolidated Results
Press Release on Q2 Results
Q2 Segmentwise Update
Q2 Investor Update
Q2, FY 2016 Con call Transcript
Q2, FY 2016 Con call Transcript
Stand Alone Results
Consolidated Results
Press Release on Q3 Results
Q3 Segmentwise Update
Q3, FY 2016 Con call Transcript
Q3, FY 2016 Con call Transcript
Stand Alone Results
Consolidated Results
Press Release on Q4 Results
Q4 Segmentwise Update
Q4, FY 2016 Con call Transcript
Stand Alone Results
Consolidated Results
Details of Nodal Officer
Name
: Chintan Trivedi
Designation
: Company Secretary
E-mail Id
: investorservices@torrentpharma.com
IEPF Authority - Refund web page
IEPF Authority - Refund web page >>
